Ovarian cancer biomarkers in urine

被引:28
作者
Chambers, AF
Vanderhyden, BC
机构
[1] Univ Western Ontario, London Reg Canc Program, Dept Oncol, London, ON N6A 4L6, Canada
[2] Univ Ottawa, Dept Cellular & Mol Med, Ctr Canc Therapeut, Ottawa Hlth Res Inst, Ottawa, ON, Canada
关键词
D O I
10.1158/1078-0432.CCR-05-2563
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:323 / 327
页数:5
相关论文
共 48 条
[11]   Surgical standards in the management of ovarian cancer [J].
Bristow, RE .
CURRENT OPINION IN ONCOLOGY, 2000, 12 (05) :474-480
[12]   Carcinosarcoma of the ovary - 19 years of prospective data from a single center [J].
Brown, E ;
Stewart, M ;
Rye, T ;
Al-Nafussi, A ;
Williams, ARW ;
Bradburn, M ;
Smyth, J ;
Gabra, H .
CANCER, 2004, 100 (10) :2148-2153
[13]  
Eiján AM, 2000, ONCOL REP, V7, P1395
[14]  
EINHORN N, 1992, OBSTET GYNECOL, V80, P14
[15]  
Eltabbakh G H, 2001, Expert Opin Pharmacother, V2, P109, DOI 10.1517/14656566.2.1.109
[16]  
Fedarko NS, 2001, CLIN CANCER RES, V7, P4060
[17]   Expression and characterization of recombinant osteopontin peptides representing matrix metalloproteinase proteolytic fragments [J].
Gao, YA ;
Agnihotri, R ;
Vary, CPH ;
Liaw, L .
MATRIX BIOLOGY, 2004, 23 (07) :457-466
[18]   Osteopontin: a versatile regulator of inflammation and biomineralization [J].
Giachelli, CM ;
Steitz, S .
MATRIX BIOLOGY, 2000, 19 (07) :615-622
[19]   Plasma osteopontin - Associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma [J].
Hotte, SJ ;
Winquist, EW ;
Stitt, L ;
Wilson, SM ;
Chambers, AF .
CANCER, 2002, 95 (03) :506-512
[20]  
HURTEAU JA, 1995, CANCER, V76, P1615, DOI 10.1002/1097-0142(19951101)76:9<1615::AID-CNCR2820760918>3.0.CO